Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
11,861,778
-
Shares change
-
+5,135,807
-
Total reported value, excl. options
-
$22,968,985
-
Value change
-
+$8,855,507
-
Number of buys
-
24
-
Number of sells
-
-9
-
Price
-
$1.94
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q3 2015
41 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q3 2015.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,861,778 shares
.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP LLC (1,700,000 shares), Abingworth LLP (1,600,000 shares), Lombard Odier Asset Management (USA) Corp (1,098,198 shares), Versant Venture Management, LLC (1,048,601 shares), Point72 Asset Management, L.P. (1,035,288 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (950,000 shares), ARMISTICE CAPITAL, LLC (836,000 shares), Omega Fund Management, LLC (650,000 shares), VANGUARD GROUP INC (427,907 shares), and Ghost Tree Capital, LLC (400,000 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.